McKinley Carter Wealth Services’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-393
Closed -$204K 296
2024
Q3
$204K Hold
393
0.01% 300
2024
Q2
$213K Hold
393
0.01% 290
2024
Q1
$204K Buy
+393
New +$195K 0.01% 293
2023
Q1
Sell
-393
Closed -$202K 300
2022
Q4
$202K Buy
+393
New +$200K 0.02% 285
2021
Q3
Sell
-542
Closed -$207K 291
2021
Q2
$207K Buy
+542
New +$207K 0.02% 277
2020
Q3
Sell
-10,748
Closed -$2.83M 141
2020
Q2
$2.83M Buy
10,748
+1,179
+12% +$315K 0.69% 43
2020
Q1
$2.17M Buy
9,569
+678
+8% +$185K 0.65% 40
2019
Q4
$2.69M Buy
8,891
+406
+5% +$112K 0.63% 40
2019
Q3
$2.04M Buy
8,485
+157
+2% +$43K 0.52% 48
2019
Q2
$2.35M Buy
8,328
+1,070
+15% +$292K 0.63% 43
2019
Q1
$2.08M Buy
+7,258
New +$2.1M 0.58% 46
2018
Q2
Sell
-329
Closed -$72K 231
2018
Q1
$72K Buy
+329
New +$77.3K 0.02% 232

Other funds holding ELV

McKinley Carter Wealth Services's ELV Position: Q4 2024 in Review

McKinley Carter Wealth Services sold out of Elevance Health (ELV) in Q4 2024, closing a stake of 393 shares — an estimated $204K sold.

McKinley Carter Wealth Services first reported a position in ELV in Q1 2018 and held it in 12 quarters. The position peaked at $2.83M in Q2 2020. 1,602 funds tracked by Wall St. Rank hold ELV as of Q4 2024.

  • McKinley Carter Wealth Services reported no remaining Elevance Health position as of Q4 2024 after selling out during the quarter.
  • McKinley Carter Wealth Services sold 393 Elevance Health shares in Q4 2024, an estimated $204K.
  • McKinley Carter Wealth Services first reported a position in Elevance Health in Q1 2018 and held it in 12 quarters.
  • McKinley Carter Wealth Services's Elevance Health position peaked at $2.83M in Q2 2020.
  • 1,602 funds tracked by Wall St. Rank held Elevance Health as of Q4 2024.

Based on McKinley Carter Wealth Services's 13F filing for Q4 2024, filed 23 Jan 2025.